Interestingly, despite differences in pathway activation between tumours and CLs, AKT downstream effectors related to cell cycle, cell survival regulation, and p53 signalling activation were predominantly upregulated across all sample groups but basal-like tumours (Fig. 3). This evidence concerns the gene TP53 and neoplasm.